Worldwide Clinical Trials, Research Triangle park, North Carolina, USA
 Review Article   
								
																Patient Segmentation in ALS Studies 
																Author(s): Michael F Murphy*, Erin M Griner, William L Slone, Andrew Kuhlman and Tomislav Babic             
								
																
						 Does genotypic vs. phenotypic segmentation make sense in the context of an amyotrophic lateral sclerosis (ALS) study?
It’s a provocative question, but one that warrants consideration. Research into the nature of ALS points to genetic mutations, often taking the form of miss aggregated
  or misfolded proteins. More than 20 genes have been causally linked to ALS. Four genetic mutations are common; the others are relatively rare . Certain genetic
  mutations appear to run in families but the same mutations can also be found in sporadic (i.e., non-familial) cases. These mutations have formed the basis for past patient
  segmentation efforts but there is reason to question whether such segmentation efforts have any relevance to the presentation of ALS itself. Do these genetic mutations
  actually express different phenotypes? Do they play any role in the sign, symptoms, o.. Read More»
						  
																DOI:
								10.37421/2795-6172.2021.5.129															  
Journal of Clinical Research received 11 citations as per Google Scholar report